National Institute of Allergy and Infectious Diseases director Anthony S. Fauci, M.D., returns to JAMA’s Q&A series to discuss shifts in the U.S. pandemic response under the Biden administration, emerging genetic variants and implications for vaccine efficacy and prospects for new vaccine approvals and more.

The journey to a post-COVID era is a difficult one. Although two promising vaccines are currently authorized for emergency use and more than 4.2 million people received the first of two required doses as of January 3, 2021, the United States fell short of its goal to inoculate 20 million front-line workers and seniors in December 2020.

This webinar offers an opportunity for members of the media to learn about the stories and challenges to anticipate related to COVID-19 vaccines, and to learn how to apply the latest insights from the social sciences and seasoned science journalists to their craft.

A year into the global COVID-19 pandemic, physicians and researchers are battling two newly frustrating phenomena: the spread of novel coronavirus variants with potential to undermine patients’ immune-system defenses, and a mysterious long-lasting medical syndrome in survivors, for which there remains no definitive treatment. SciLine’s next media briefing will delve into the latest research on these biomedical challenges, and provide reporters with opportunities for Q&A.

The COVID-19 pandemic led to an unprecedented demand for nurses to provide hospital and other forms of care. The burden has been devastating for nurses, who comprise America’s largest health care workforce. As a result, nurses are leaving the workforce due to burnout, a lack of child care, contracting COVID-19 themselves, or other health concerns, accelerating an already existing nursing shortage in the United States. As nurses continue to provide most of the nation’s care, it is critical to explore strategies to support them, raise their voices as trusted messengers in media and other forums, and strengthen the nursing workforce.

The burden of COVID-19 has been devastating for nurses. The pandemic has highlighted the critical need for nurses and how a lack of support for them impacts patient care, vaccine access and hesitancy, existing workforce shortages, and the ability of the health care system to function.

A new webinar series hosted by the Duke Global Health Institute will explore the history and drivers of vaccine hesitancy and discuss strategies to overcome vaccine concerns, including lessons learned from past disease eradication efforts.

Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Our monthly “Science Says” researcher roundtable features scientists who are leading vaccine trials, guiding public health policy, tracking genetic changes to the virus, and studying new treatments for COVID-19.

The National Academy of Medicine and the American Public Health Association (APHA) will host the 17th COVID-19 Conversations webinar on the current state of the pandemic in the U.S. and new and continuing federal-level initiatives to curb and control the virus.

COVID-19 treatments exemplify the significance of the public-private sector R&D continuum. While these treatments have not generally received the same level of attention as vaccines, they are critical to our response to the pandemic. This panel discussion will explore the range of treatments available; how, when, and in what settings they are administered; and ways to ensure these treatments reach patients in need.